Shots: The AURORA 2 involves assessing Lupkynis vs control arm in 216 patients who have completed P-III AURORA 1 study for 1 year Results: reduction in UPCR from pre-treatment baseline […]readmore
Tags : Lupus Nephritis
Shots: The P-II NOBILITY study involves assessing of Gazyva + mycophenolate mofetil/ mycophenolic acid and corticosteroids vs PBO + MMF/MPA and corticosteroids in 125 patients with ISN/RPS 2003 class III […]readmore
Shots: The FDA’s BT designation is based on P-II NOBILITY (NCT02550652) study assessing Gazyva in combination with mycophenolate mofetil/mycophenolic acid and corticosteroids vs PBO + MMF/MPO and corticosteroids in 126 […]readmore